Target intelligence / Profile preview

Ribonucleotide reductase M2 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

Ribonucleotide reductase M2 pseudogene (ENSG00000271364, LOC100420205) denotes a pseudogene related to the ribonucleotide reductase M2 (RRM2) gene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they arise from gene duplication or retrotransposition and generally do not encode functional proteins. There is no evidence this locus produces a functional ribonucleotide reductase subunit or has a direct role in cellular or disease processes[4].

Other names
LOC100420205

Beyond the preview

Go deeper on Ribonucleotide reductase M2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribonucleotide reductase M2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call